Who is the CEO of NovMetaPharma?

According to the DART company overview, NovMetaPharma's representative director is 황선욱, 정회윤 (각자 대표) (name as registered in Korean). The company was founded on 2010-11-04.

Where is NovMetaPharma listed?

NovMetaPharma trades on the Korea Exchange KONEX market under the ticker 229500. Its fiscal year ends in December.

Does NovMetaPharma pay a dividend?

NovMetaPharma did not pay a cash dividend for fiscal 2025, according to its annual report.

Which companies are in the same industry as NovMetaPharma?

Under the Korean Standard Industrial Classification recorded on DART, NovMetaPharma is grouped with 52 other listed companies in medical & pharmaceutical r&d. The most covered in Korean news over the past 30 days are Alteogen, Qurient and Vaxcell-Bio Therapeutics.

NovMetaPharma KRX:229500KONEX

노브메타파마 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days0

DART filings, 7 days1

Articles tracked0since Sep 11

NovMetaPharma (노브메타파마) appeared in 0 Korean news articles and 1 DART filing over the past seven days.

NovMetaPharma top stories 2 weeks, by number of outlets

No story covered by multiple outlets in the past two weeks.

Latest NovMetaPharma news Korean headlines

No articles yet.

Articles per day 2 weeks

Company profile

CEO: 황선욱, 정회윤 (각자 대표)
Industry: Medical & pharmaceutical R&D
Founded: 2010-11-04
Fiscal year-end: December
Head office: 서울특별시 강남구
Website: novmeta.com
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Same industry Medical & pharmaceutical R&D

All in industry

Company	Latest quarter op. profit	Articles 30d
Alteogen	₩34.2bn	55
Qurient	−₩12.8bn	26
Vaxcell-Bio Therapeutics	−₩5.0bn	22
OliX Pharmaceuticals	−₩14.0bn	20
Penetrium Bioscience	−₩1.9bn	19
Aribiolab	−₩2.5bn	15
LigaChem Biosciences	−₩72.0bn	14
ImmuneOncia Therapeutics	−₩4.3bn	14

Compare NovMetaPharma side by side with these companies

NovMetaPharma DART filings

Sep 2816:01

Investor relations event 기업설명회(IR)개최
Other

Mentioned alongside 2 weeks

No co-mentioned companies yet.

NovMetaPharma FAQ

Who is the CEO of NovMetaPharma?: According to the DART company overview, NovMetaPharma's representative director is 황선욱, 정회윤 (각자 대표) (name as registered in Korean). The company was founded on 2010-11-04.
Where is NovMetaPharma listed?: NovMetaPharma trades on the Korea Exchange KONEX market under the ticker 229500. Its fiscal year ends in December.
Does NovMetaPharma pay a dividend?: NovMetaPharma did not pay a cash dividend for fiscal 2025, according to its annual report.
Which companies are in the same industry as NovMetaPharma?: Under the Korean Standard Industrial Classification recorded on DART, NovMetaPharma is grouped with 52 other listed companies in medical & pharmaceutical r&d. The most covered in Korean news over the past 30 days are Alteogen, Qurient and Vaxcell-Bio Therapeutics.